Argos Therapeutics' Arcelis™ Immunotherapy for Renal Cell Carcinoma ... - PR-CANADA.net (press release) PDF Print
PR-CANADA.net (press release)Argos Therapeutics announced that its Arcelis immunotherapy for renal cell carcinoma (RCC), AGS-003, demonstrated favorable progression-free survival (PFS)

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.